Ayca Dilruba Aslanger

Ayca Dilruba Aslanger

Auto-generated profile, based on publicly available information

Ayca Dilruba Aslanger

Department of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2023 in Brain
Verified
Journal Article
Open access
PDF file
RMReza Maroofian
Reza Maroofian
RKRauan Kaiyrzhanov
Rauan Kaiyrzhanov
ECElisa Cali
Elisa Cali
MZMina Zamani
Mina Zamani
MZMaha S Zaki
Maha S Zaki
MSMariasavina Severino
Mariasavina Severino
MED27 is a subunit of the Mediator multiprotein complex, which is involved in transcriptional regulation. Biallelic MED27 variants have recently been suggested to be responsible for an autosomal recessive neurodevelopmental disorder with spasticity, cataracts and cerebellar hypoplasia. We further delineate the clinical phenotype of MED27-related disease by characterizing the clinical and radiological features of 57 affected individuals from 30 unrelated families with biallelic MED27 variants. Using exome sequencing and extensive international genetic data sharing, 39 unpublished affected individuals from 18 independent families with biallelic missense variants in MED27 have been identified (29 females, mean age at last follow-up 17 ± 12.4 years, range 0.1–45). Follow-up and hitherto unreported clinical features were obtained from the published 12 families. Brain MRI scans from 34 cases were reviewed. MED27-related disease manifests as a broad phenotypic continuum ranging from developmental and epileptic-dyskinetic encephalopathy to variable neurodevelopmental disorder with movement abnormalities. It is characterized by mild to profound global developmental delay/intellectual disability (100%), bilateral cataracts (89%), infantile hypotonia (74%), microcephaly (62%), gait ataxia (63%), dystonia (61%), variably combined with epilepsy (50%), limb spasticity (51%), facial dysmorphism (38%) and death before reaching adulthood (16%). Brain MRI revealed cerebellar atrophy (100%), white matter volume loss (76.4%), pontine hypoplasia (47.2%) and basal ganglia atrophy with signal alterations (44.4%). Previously unreported 39 affected individuals had seven homozygous pathogenic missense MED27 variants, five of which were recurrent. An emerging genotype-phenotype correlation was observed. This study provides a comprehensive clinical-radiological description of MED27-related disease, establishes genotype-phenotype and clinical-radiological correlations and suggests a differential diagnosis with syndromes of cerebello-lental neurodegeneration and other subtypes of ‘neuro-MEDopathies’.

5 January 2022 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
AAAyca Dilruba Aslanger
Ayca Dilruba Aslanger
BGBeyza Goncu
Beyza Goncu
ODOmer Faruk Duzenli
Omer Faruk Duzenli
EYEmrah Yucesan
Emrah Yucesan
ESEsma Sengenc
Esma Sengenc
GYGozde Yesil
Gozde Yesil

29 October 2013 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
AAAyca D. Aslanger
Ayca D. Aslanger
UAUmut Altunoglu
Umut Altunoglu
EAEmre Aslanger
Emre Aslanger
BSBilge N. Satkın
Bilge N. Satkın
OUOya Zehra Uyguner
Oya Zehra Uyguner
HKHülya Kayserili
Hülya Kayserili

11 July 2012 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
BKBülent Kara
Bülent Kara
BEBarış Ekici
Barış Ekici
BİBelkıs İpekçi
Belkıs İpekçi
AAAyça Koçbaş Aslanger
Ayça Koçbaş Aslanger
USUte Scholl
Ute Scholl

5 May 2020 in Neuropediatrics
Verified
Journal Article
Closed access
PDF file
AAAyca Dilruba Aslanger
Ayca Dilruba Aslanger
EDEmine Demiral
Emine Demiral
SSSeyma Sonmez-Sahin
Seyma Sonmez-Sahin
SGSerhat Guler
Serhat Guler
BGBeyza Goncu
Beyza Goncu
GYGozde Yesil
Gozde Yesil
Biallelic mutations in the TRAPPC12 gene are responsible for early-onset progressive encephalopathy with brain atrophy and spasticity (PEBAS). To date, three different allelic variants have been reported. Next-generation sequencing allowed discovery of unique alternations in this gene with different phenotypes. We report two patients carrying TRAPPC12 variants, one previously reported and one unknown mutation, with severe neurodevelopmental delay and brain atrophy. Standard clinical examination and cranial imaging studies were performed in these two unrelated patients. In addition, whole-exome sequencing was performed, followed by Sanger sequencing for verification. The first patient, a 2-year-old boy, was found to be homozygous for the previously reported c.1880C > T (p.Ala627Val) mutation. He presented with a phenotype including severe progressive cortical atrophy, moderate cerebellar atrophy, epilepsy, and microcephaly, very similar to the previously reported cases. The second case, a 9-year-old boy, carried a novel homozygous c.679T > G (p.Phe227Val) variant and presented with mild cortical atrophy, severe cerebellar atrophy, and neither clinically manifest epilepsy nor microcephaly, which were previously considered typical findings in PEBAS with TRAPPC12 mutations. Our findings suggest that clinical and brain imaging findings might be more variable than previously anticipated; however, a larger number of observations would benefit for broader phenotypic spectrum.

1 December 2022 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
BYBurcu Yeter
Burcu Yeter
AAAyca Dilruba Aslanger
Ayca Dilruba Aslanger
GYGözde Yeşil
Gözde Yeşil
NENursel Elcioglu
Nursel Elcioglu
Odontochondrodysplasia (ODCD, OMIM #184260) is a quite rare non-lethal skeletal dysplasia characterized by involvement of the spine and metaphyseal regions of the long bones, pulmonary hypoplasia, short stature, joint hypermobility, and dentinogenesis imperfecta. ODCD is inherited in an autosomal recessive fashion with an unknown frequency caused by mutations of the thyroid hormone receptor interactor 11 gene (TRIP11; OMIM *604505). TRIP11 gene encodes the Golgi microtubule-associated protein 210 (GMAP-210), which is an indispensable protein for the function of the Golgi apparatus. Mutations of the TRIP11 gene also cause achondrogenesis type 1A (ACG1A). Null mutations of TRIP11 lead to ACG1A, also known as a lethal skeletal dysplasia, while hypomorphic mutations cause ODCD. Here we report a male child diagnosed as ODCD with a novel compound heterozygote mutation who presented with skeletal changes, short stature, dentinogenesis imperfecta, and facial dysmorphism resembling Achondroplasia (ACH) and Hypochondroplasia (HCH).